Cargando…

Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis

BACKGROUND: Cryptosporidium parvum is an important coccidian parasite infecting many mammals, including human. This parasite can manifest as chronic severe diarrhea in immunocompromised individuals, especially those with AIDS. The present study reports the recombinant production of rP2 and rP23 anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzegar, Gholamreza, Ahmadpour, Ehsan, Shahriari, Bahador, Solgi, Rahmat, Motazedian, Mohammad Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute of Iran 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763877/
https://www.ncbi.nlm.nih.gov/pubmed/36369769
http://dx.doi.org/10.52547/ibj.3801
_version_ 1784853159120732160
author Barzegar, Gholamreza
Ahmadpour, Ehsan
Shahriari, Bahador
Solgi, Rahmat
Motazedian, Mohammad Hossein
author_facet Barzegar, Gholamreza
Ahmadpour, Ehsan
Shahriari, Bahador
Solgi, Rahmat
Motazedian, Mohammad Hossein
author_sort Barzegar, Gholamreza
collection PubMed
description BACKGROUND: Cryptosporidium parvum is an important coccidian parasite infecting many mammals, including human. This parasite can manifest as chronic severe diarrhea in immunocompromised individuals, especially those with AIDS. The present study reports the recombinant production of rP2 and rP23 antigens of C. parvum as antigens for detecting human cryptosporidiosis using indirect ELISA tests. METHODS: The coding sequences of rP2 and rP23 proteins were codon-optimized, commercially synthesized and sub-cloned in the pET28a expression vector. The expressed proteins were purified by Ni-NTA column chromatography and confirmed by Western blotting. The efficacy of rP2/rP23 proteins for serodiagnosis was evaluated by positive (n = 20) and negative (n = 20) human sera, confirmed by the Ziehl-Neelsen staining as the gold standard test. RESULTS: In ELISA test, the sera from C. parvum-infected patients reacted strongly to rP2/rP23. The sensitivity and specificity related to the diagnostic potential of rP2/rP23 in the ELISA assay were 100%. CONCLUSION: Our results showed that combination of rP23 and rP2 antigens in ELISA significantly increases the performance of C. parvum serodiagnosis in human cryptosporidiosis.
format Online
Article
Text
id pubmed-9763877
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Pasteur Institute of Iran
record_format MEDLINE/PubMed
spelling pubmed-97638772022-12-27 Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis Barzegar, Gholamreza Ahmadpour, Ehsan Shahriari, Bahador Solgi, Rahmat Motazedian, Mohammad Hossein Iran Biomed J Full Length BACKGROUND: Cryptosporidium parvum is an important coccidian parasite infecting many mammals, including human. This parasite can manifest as chronic severe diarrhea in immunocompromised individuals, especially those with AIDS. The present study reports the recombinant production of rP2 and rP23 antigens of C. parvum as antigens for detecting human cryptosporidiosis using indirect ELISA tests. METHODS: The coding sequences of rP2 and rP23 proteins were codon-optimized, commercially synthesized and sub-cloned in the pET28a expression vector. The expressed proteins were purified by Ni-NTA column chromatography and confirmed by Western blotting. The efficacy of rP2/rP23 proteins for serodiagnosis was evaluated by positive (n = 20) and negative (n = 20) human sera, confirmed by the Ziehl-Neelsen staining as the gold standard test. RESULTS: In ELISA test, the sera from C. parvum-infected patients reacted strongly to rP2/rP23. The sensitivity and specificity related to the diagnostic potential of rP2/rP23 in the ELISA assay were 100%. CONCLUSION: Our results showed that combination of rP23 and rP2 antigens in ELISA significantly increases the performance of C. parvum serodiagnosis in human cryptosporidiosis. Pasteur Institute of Iran 2022-09 2022-10-29 /pmc/articles/PMC9763877/ /pubmed/36369769 http://dx.doi.org/10.52547/ibj.3801 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Full Length
Barzegar, Gholamreza
Ahmadpour, Ehsan
Shahriari, Bahador
Solgi, Rahmat
Motazedian, Mohammad Hossein
Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis
title Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis
title_full Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis
title_fullStr Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis
title_full_unstemmed Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis
title_short Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis
title_sort use of recombinant cp2 and cp23 antigens of cryptosporidium parvum for serodiagnosis of human cryptosporidiosis
topic Full Length
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763877/
https://www.ncbi.nlm.nih.gov/pubmed/36369769
http://dx.doi.org/10.52547/ibj.3801
work_keys_str_mv AT barzegargholamreza useofrecombinantcp2andcp23antigensofcryptosporidiumparvumforserodiagnosisofhumancryptosporidiosis
AT ahmadpourehsan useofrecombinantcp2andcp23antigensofcryptosporidiumparvumforserodiagnosisofhumancryptosporidiosis
AT shahriaribahador useofrecombinantcp2andcp23antigensofcryptosporidiumparvumforserodiagnosisofhumancryptosporidiosis
AT solgirahmat useofrecombinantcp2andcp23antigensofcryptosporidiumparvumforserodiagnosisofhumancryptosporidiosis
AT motazedianmohammadhossein useofrecombinantcp2andcp23antigensofcryptosporidiumparvumforserodiagnosisofhumancryptosporidiosis